Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12668803.
- Also identified by PMC identifier 1746634.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of chemotherapy for NSCLC over the last 20 years is reviewed, particularly with regard to its palliative effects. New "fourth generation" agents designed to inhibit specific biological pathways thought to be crucial to tumour growth give cause for optimism in the future treatment of NSCLC.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms